Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pancreatic Neoplasms 4Neoplasms 3Multiple Myeloma 3Sarcoma 2Neoplasms, Plasma Cell 2Fatigue 1Desmoplastic Small Round Cell Tumor 1Carcinoma 1Breast Neoplasms 1Bone Neoplasms 1Adenocarcinoma 1

Interventions

Therapeutics 5Psychiatric Rehabilitation 2Amplified Fragment Length Polymorphism Analysis 2reparixin 1Walking 1Tai Ji 1Sildenafil Citrate 1Saline Solution 1Reverse Transcriptase Polymerase Chain Reaction 1Rehabilitation 1Qigong 1Polymerase Chain Reaction 1Music Therapy 1Modafinil 1Microarray Analysis 1Holistic Health 1Gene Expression Profiling 1Exercise 1Epoetin Alfa 1Enzyme-Linked Immunosorbent Assay 1Educational Status 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Fatigue × Ascorbic Acid × Clear all
NCT02521077 2017-06-27

Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer

Midwestern Regional Medical Center

Phase 2 Withdrawn
Breast

Breast Neoplasms, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡